Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
about
Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophyMolecular basis for impaired muscle differentiation in myotonic dystrophyHnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence.Muscle wasting in myotonic dystrophies: a model of premature agingExpression of evolutionarily conserved eye specification genes during Drosophila embryogenesisSkeletal muscle Na currents in mice heterozygous for Six5 deficiencyThe sine oculis homeobox (SIX) family of transcription factors as regulators of development and diseaseSix4, a putative myogenin gene regulator, is not essential for mouse embryonal development.Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy.Cat-Map: putting cataract on the mapDoes (CUG)n repeat in DMPK mRNA 'paint' chromosome 19 to suppress distant genes to create the diverse phenotype of myotonic dystrophy?: A new hypothesis of long-range cis autosomal inactivation.Dystrophia myotonia: why focus on foci?Increased SK3 expression in DM1 lens cells leads to impaired growth through a greater calcium-induced fragility.Myotonic dystrophy: RNA pathogenesis comes into focus.Changes in myotonic dystrophy protein kinase levels and muscle development in congenital myotonic dystrophyUncovering the Role of Hypermethylation by CTG Expansion in Myotonic Dystrophy Type 1 Using Mutant Human Embryonic Stem CellsNeurodegeneration the RNA wayMisregulation of alternative splicing causes pathogenesis in myotonic dystrophy.Epigenetics in nucleotide repeat expansion disorders.Antisense oligonucleotides: rising stars in eliminating RNA toxicity in myotonic dystrophy.Pluralistic and stochastic gene regulation: examples, models and consistent theory.RNA-mediated toxicity in neurodegenerative diseaseSine oculis, a member of the SIX family of transcription factors, directs eye formationNovel dominant-negative mutation within the six domain of the conserved eye specification gene sine oculis inhibits eye development in Drosophila.A Potent Inhibitor of Protein Sequestration by Expanded Triplet (CUG) Repeats that Shows Phenotypic Improvements in a Drosophila Model of Myotonic Dystrophy.Myotonic dystrophy mouse models: towards rational therapy development.The lens in focus: a comparison of lens development in Drosophila and vertebrates.Epigenetic changes and non-coding expanded repeats.Repeat expansion disease: progress and puzzles in disease pathogenesisPerspectives on gene therapy in myotonic dystrophy type 1.Molecular mechanisms in DM1 - a focus on foci.Activation of the innate immune response and interferon signalling in myotonic dystrophy type 1 and type 2 cataracts.Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy.Environmental suppression of Neurospora crassa cot-1 hyperbranching: a link between COT1 kinase and stress sensing.Novel genetic loci associated with long-term deterioration in blood lipid concentrations and coronary artery disease in European adults.Abnormal contractile activity and calcium cycling in cardiac myocytes isolated from DMPK knockout mice.250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1.Myotonic dystrophy type 1: frequency of ophthalmologic findings.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.
P2860
Q24290177-04C734CB-BE6D-460A-BE4D-0FF81B2EDC9AQ24548314-AFA1A818-42FC-44DD-9D2B-F7EA7FE6C4B4Q24812815-B47A2C07-81FA-43D6-AAC1-528CB6F51DA5Q26798784-70D3FBAF-E3FB-41B1-9B00-EE2F0260CCD5Q28362878-849D99C9-5BDC-44C1-AF42-3754E3538BC7Q28505273-02C0894A-6010-4782-8765-922B4D5E28D8Q28752140-79CE363A-357F-4811-BA61-732CC0F2AA47Q30531281-D1B64285-FEED-441C-AECC-5CF4E6809249Q33548657-49FA98DD-6A36-4E92-88D8-267ED04E09F5Q34248597-F6354F0C-24D1-47B6-8FE8-DE983E79DE7DQ34252137-1E9BF042-D728-4358-B3BA-695B65D01B03Q34326165-F9919D63-EFB7-4393-A222-EB41A7E69DA1Q34581298-7953E062-6964-44A9-8F36-6FE29E80E6D4Q35738537-7571E5F8-7780-41F9-A512-D91E8309CEE0Q35791378-98458024-F55F-4329-8C04-C730AAC10778Q36201577-6371EFF0-656D-477A-B89B-760475599C68Q36638284-5ABC6488-1F23-489F-8402-9817AAA4CB31Q36640173-45ECFD66-038B-4DB2-B096-DB18CA904B04Q36848454-19DCC2A1-AE72-4372-8A86-E96D9C1F2DEAQ36848720-4D07FE9B-F940-41B5-B655-50B5352EB5E2Q36958965-C7A5539E-F54D-4FAB-986F-C0A1F62A3C2EQ37216891-0F3ADDB1-FE25-4346-A8EB-AB29A6076E29Q37286019-88684779-C78A-437B-87AD-16A80D16BD07Q37331620-4A7AEBCA-D3C2-4EF8-ADB4-D60E42927FFFQ37358384-783B9494-6959-4845-81E4-EF1750E5E985Q37434343-FDB9E0F6-6E82-47E5-87B5-8867F4407579Q37573004-7F49217A-C5CF-4B92-9604-1AA8AF3D7616Q37695480-4FED8253-10B6-4DB9-BAB0-408EC29DCF00Q37696972-70AB167A-9784-4297-AF5D-4FC5ECA211C8Q37831858-A1027243-49A8-43A7-A02C-FBDAD82C8972Q38326275-CB9E9886-73AF-4EF7-A575-17D4FF612663Q38330480-CEC60774-7619-4FB3-BF3F-C1F0C130878BQ39533050-6C6242B8-0D61-4022-A8E0-6A97B7E9AAA4Q39842654-6CB72F3F-66D8-4B66-BE5F-1E801F79D2ECQ40467411-B891E8D4-0B3A-4668-8DFD-350057ACD210Q42437310-83444678-AB83-46A7-A52E-4C49E814ABB3Q47194897-561B8F4F-90BB-498F-BA13-0EB4B425B167Q52668446-D8B68FC9-B222-4FD6-A4AA-A56D4E72AA31Q53719522-EDA9A006-5286-4BD7-9F67-DD1A3AD1DEC5Q54982478-325BE702-1B8F-460D-BE8E-91F675F89AF8
P2860
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
description
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
articolo scientifico
@it
artículu científicu espublizáu en 2000
@ast
im Mai 2000 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2000/05/01)
@sk
vědecký článek publikovaný v roce 2000
@cs
wetenschappelijk artikel (gepubliceerd op 2000/05/01)
@nl
наукова стаття, опублікована в травні 2000
@uk
name
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@ast
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@en
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@nl
type
label
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@ast
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@en
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@nl
prefLabel
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@ast
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@en
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@nl
P2093
P2860
P3181
P356
P1433
P1476
Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts
@en
P2093
B. Appukuttan
J. T. Stout
P. S. Sarkar
P2860
P2888
P304
P3181
P356
10.1038/75500
P407
P577
2000-05-01T00:00:00Z